Levity Ozempic Cost: First-Month Rate vs Standard Refill Price

Last reviewed: September 5, 2026 Last updated: September 5, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Levity offers FDA-approved branded Ozempic at $1,149 for the first month (using promotional code WELCOME) and $1,199 per month thereafter, captured September 4, 2026. That first-month rate represents a $50 introductory discount; renewal billing is $1,199 monthly with no membership fee, and the package includes consultation, medication, and shipping. Over 12 months the total is $14,338, or an effective average of $1,194.83 per month. Levity sells FDA-approved branded medication; PlexusDx and many telehealth competitors offer compounded semaglutide—a different regulatory category—at dramatically lower prices ($189/month at PlexusDx). The $1,000+ monthly price difference reflects the branded-versus-compounded distinction, not service quality. Choose Levity if you specifically need or prefer FDA-approved branded Ozempic and are prepared for the associated cost; choose a compounded option if a licensed provider determines that compounded semaglutide is appropriate for you and cost is a material constraint.

At-a-glance: Levity Ozempic pricing vs compounded semaglutide

Levity pricing captured September 4, 2026 from joinlevity.com; PlexusDx pricing captured July 17–23, 2026.

Levity's Ozempic pricing structure in detail

Levity's website shows a first-month price of $1,149 for branded Ozempic when the promotional code WELCOME is applied at checkout, verified during intake on September 4, 2026. After the first supply, the recurring monthly charge is $1,199. This structure means a patient pays $1,149 up front, then $1,199 approximately every four weeks thereafter. The $50 difference between first-month and renewal pricing is Levity's standard introductory discount, not a limited-time promotion with an expiration date captured in our research.

That $1,199 monthly fee is all-inclusive: it covers the branded Ozempic medication, an initial consultation with a licensed provider who reviews your medical history, current medications, contraindications, and determines whether Ozempic is appropriate and writes the prescription if so, ongoing care access, and shipping. Levity charges no separate membership fee, and the company's terms allow cancellation at any time. The billing cadence follows the medication supply cycle—roughly four weeks per pen—so "monthly" in practice may vary slightly depending on dosing and supply duration.

Levity also offers other FDA-approved GLP-1 brands captured at the same session: Mounjaro (branded tirzepatide) at $1,249 first month and $1,299 ongoing, and Wegovy (branded semaglutide approved specifically for weight management) at $1,549 first month and $1,599 ongoing. All three follow the same $50 first-month discount model. This analysis focuses on Ozempic because the assigned topic centers on that medication, but the pricing architecture is consistent across Levity's branded product line.

Twelve-month cost: how the first-month discount affects the annual total

A straightforward 12-month cost calculation for Levity's Ozempic plan, assuming continuous month-to-month enrollment:

• Month 1: $1,149 (introductory rate with WELCOME code)
• Months 2–12 (11 refills): $1,199 × 11 = $13,189
• Total: $1,149 + $13,189 = $14,338
• Effective monthly average: $14,338 ÷ 12 = $1,194.83

That $1,194.83 figure is our calculation and represents the true recurring cost when the one-time $50 discount is averaged across a year. The first-month savings reduce the annual burden by $50 total—meaningful in absolute terms but modest relative to the $14,338 annual outlay.

For comparison, PlexusDx's compounded semaglutide injection on a month-to-month plan costs $189 per month with no first-month discount, yielding a 12-month total of $2,268 (our calculation). A patient on Levity's branded Ozempic would pay $14,338 − $2,268 = $12,070 more per year than a patient on PlexusDx's compounded semaglutide, assuming both remain on the respective programs for 12 months. That difference is not a function of plan design, membership fees, or ancillary charges—it reflects the price of FDA-approved branded medication versus compounded pharmacy preparation.

Branded Ozempic vs compounded semaglutide: what the price difference reflects

The $1,000+ monthly gap between Levity's Ozempic and PlexusDx's compounded semaglutide requires explanation, because the two products share the same active pharmaceutical ingredient—semaglutide—but exist in different regulatory and manufacturing categories.

Ozempic is a branded medication manufactured by Novo Nordisk and approved by the FDA under a New Drug Application (NDA). That approval process requires the manufacturer to demonstrate safety and efficacy through Phase I, II, and III clinical trials, establish manufacturing quality standards, and conduct post-market surveillance. The FDA reviews every batch, labeling claim, and manufacturing change. Ozempic is FDA-approved for type 2 diabetes; clinicians may prescribe it off-label for weight management, a common and legally supported practice.

Compounded semaglutide is prepared by a licensed 503A compounding pharmacy—typically combining semaglutide active pharmaceutical ingredient, bacteriostatic water, and other excipients—in response to an individual patient prescription. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. Compounding pharmacies operate under state boards of pharmacy and must meet USP <795> and <797> standards, but they do not submit an NDA, conduct Phase III trials, or obtain FDA approval for the finished product. PlexusDx works with licensed 503A compounding pharmacies.

The price difference primarily reflects the branded pharmaceutical pricing model—research and development cost recovery, patent protection, brand premium—versus the ingredient-and-labor cost structure of compounding. It does not imply that one product is "better" in all contexts; it reflects two pathways to the same active ingredient, each with trade-offs in regulatory oversight, batch consistency, supply reliability, insurance coverage (branded medications may be partially covered; compounded typically are not), and cost.

A patient choosing Levity's Ozempic pays for FDA-approved branded medication with the associated regulatory assurances. A patient choosing compounded semaglutide through PlexusDx pays for a pharmacy-compounded preparation at a fraction of the cost, accepting that compounded drugs do not carry FDA approval. Both require a prescription from a licensed provider who evaluates individual fit.

What the $1,149 first month includes (and what it does not)

Levity's $1,149 first-month charge for branded Ozempic, as presented on the company's website and verified at intake on September 4, 2026, is an all-in figure. It includes:

• An initial telehealth consultation with a licensed healthcare provider who reviews your medical history, current medications, contraindications, and determines whether Ozempic is appropriate and writes the prescription if so.
• The first four-week supply of branded Ozempic (one pen, pre-filled, delivered by Novo Nordisk's distribution network or a partner pharmacy).
• Shipping to your address.
• Access to Levity's care team for questions, dose adjustments, or side-effect management during that first month.

It does not include:

• Insurance reimbursement or co-pay assistance—Levity's pricing appears to operate on a direct-pay cash basis; confirm at checkout whether insurance can be billed or whether manufacturer coupon cards (which sometimes reduce out-of-pocket costs for branded medications in certain insurance contexts) are accepted.
• Ongoing provider visits beyond the initial consultation—verify whether follow-up consultations incur separate fees or are bundled into the monthly medication cost.
• Supplies such as alcohol swabs, sharps containers, or additional needles (Ozempic pens include built-in needles).
• Dose escalation or formulation switches to other medications mid-treatment—confirm whether changing from Ozempic to Mounjaro or Wegovy incurs an additional consultation or setup fee.

The renewal charge of $1,199 per month covers the same elements—medication, care access, and shipping—minus the initial consultation, which is a one-time event unless re-enrollment is required.

When Levity's branded Ozempic is the right choice

Despite the significant cost difference compared to compounded alternatives, branded Ozempic through Levity may be the appropriate option in specific scenarios:

• If your provider or your own clinical judgment strongly prefers FDA-approved branded medication. Some patients and clinicians prioritize the regulatory assurance, batch-to-batch consistency, and post-market safety surveillance that come with an FDA-approved NDA product. If that assurance is worth the price difference to you, Levity offers a straightforward branded option with no membership fee and transparent pricing.
• If you have partial insurance coverage or manufacturer assistance. Although our research did not confirm whether Levity accepts insurance billing or Novo Nordisk savings cards, some patients may have insurance plans or employer health benefits that cover a portion of branded GLP-1 costs. If your out-of-pocket cost after insurance or manufacturer assistance is materially lower than the $1,199 listed price, the branded route may become cost-competitive with compounded alternatives. Verify coverage and assistance eligibility before committing.
• If compounded semaglutide supply is uncertain or unavailable. Compounded GLP-1 medications depend on the availability of active pharmaceutical ingredient (API) and the FDA's current shortage and compounding policy stance. If compounding pharmacies face supply constraints or regulatory changes, branded medications remain available through traditional pharmaceutical distribution. Levity's access to branded Ozempic is not subject to the same compounding-pharmacy variables.
• If you have already established care with Levity and value continuity. Switching providers mid-treatment introduces coordination overhead—new intake, new prescription, possible dose recalibration, different care team responsiveness. If you are already working with Levity's clinical team and the relationship is productive, the cost of switching to save money must be weighed against the risk of care disruption.

None of these scenarios makes Levity universally "better"—they describe contexts in which the premium for branded medication is justifiable given individual priorities, coverage, or clinical circumstances.

When compounded semaglutide through PlexusDx is the practical alternative

For most patients paying out of pocket with no insurance or manufacturer assistance and no strong clinical requirement for FDA-approved branded medication, compounded semaglutide offers the same active ingredient at a fraction of the cost:

• If cost is a binding constraint. The $12,070 difference over 12 months between Levity's Ozempic ($14,338) and PlexusDx's compounded semaglutide month-to-month ($2,268)—both figures our calculations—is sufficient to make branded medication financially inaccessible for many patients. PlexusDx's $189/month starting price ($149/month on a 6-month prepaid plan) brings semaglutide within reach for patients who would otherwise forego treatment due to cost.
• If your provider determines compounded semaglutide is appropriate. A licensed clinician determines whether a prescription is appropriate for an individual patient. If your medical history, current health status, and treatment goals support a compounded semaglutide prescription, there is no clinical requirement to choose a branded product unless your provider advises otherwise. PlexusDx's intake process includes a provider review; approval is not automatic.
• If you value pricing transparency and plan flexibility. PlexusDx publishes month-to-month, 3-month, and 6-month semaglutide injection prices ($189, $169/month prepaid, $149/month prepaid respectively) with no membership fee, no hidden charges, and the same price at every dose. Levity's pricing is also transparent (a strength relative to some competitors), but the absolute cost difference remains large.
• If you want to minimize financial commitment while evaluating medication tolerance. GLP-1 medications carry a risk of side effects—nausea, gastrointestinal distress, fatigue—that may lead a patient to discontinue treatment in the first few months. Starting on a $189/month compounded plan with cancel-anytime terms limits financial exposure during that evaluation period. Levity offers the same cancel-anytime flexibility, but each month of evaluation costs $1,149–$1,199, raising the stakes if you decide the medication is not tolerable.

PlexusDx holds a 4.2-star rating on Trustpilot, with 76% of reviews at five stars and 81% at four stars or higher (captured September 4, 2026). The company's model is built around compounded GLP-1 medications—semaglutide and tirzepatide in both injection and oral capsule formulations, plus a microdose semaglutide injection protocol—so the clinical team and fulfillment infrastructure are purpose-built for this medication class.

Other branded GLP-1 options from Levity

Although this analysis focuses on Ozempic, Levity's website (captured September 4, 2026) offers two other FDA-approved GLP-1 brands, both following the same $50 first-month discount structure:

Mounjaro (branded tirzepatide injection): $1,249 first month with code WELCOME, $1,299 per month ongoing. Mounjaro is a dual GLP-1 and GIP receptor agonist, FDA-approved for type 2 diabetes and often prescribed off-label for weight management. The dual-agonist mechanism may produce greater weight loss in some patients compared to semaglutide, though individual response varies. Over 12 months the total cost is $15,538 (our calculation), or an effective monthly average of $1,294.83. PlexusDx offers compounded tirzepatide injection at $289/month month-to-month, $269/month on a 3-month prepaid plan, or $249/month on a 6-month prepaid plan—a 12-month cost of $3,468, $3,228, or $2,988 respectively (our calculations).

Wegovy (branded semaglutide injection): $1,549 first month with code WELCOME, $1,599 per month ongoing. Wegovy is the same molecule as Ozempic—semaglutide—but FDA-approved specifically for chronic weight management rather than diabetes. The distinction is regulatory and labeling, not chemical; some insurance plans cover Wegovy for weight loss where they would not cover Ozempic off-label, though Levity's pricing appears to be cash-pay. Over 12 months the total cost is $19,138 (our calculation), or an effective monthly average of $1,594.83. PlexusDx's compounded semaglutide injection at $189/month month-to-month totals $2,268 over 12 months (our calculation), a difference of $16,870.

All three Levity plans include consultation, medication, care, and shipping with no separate membership fee and cancel-anytime terms. The choice among Ozempic, Mounjaro, and Wegovy—assuming all are clinically appropriate—depends on your provider's recommendation, your insurance or assistance situation, and whether the specific FDA-approved indication (diabetes vs weight management) matters for your coverage or clinical context.

Methodology and freshness

Levity pricing—$1,149 first month and $1,199 ongoing for branded Ozempic, $1,249/$1,299 for Mounjaro, $1,549/$1,599 for Wegovy—was captured on September 4, 2026, from the company's website at joinlevity.com and verified during a checkout intake session (no payment was submitted). The $50 first-month discount applies via promotional code WELCOME. No conflicts between sources were identified. PlexusDx pricing for compounded semaglutide and tirzepatide injections was captured July 17–23, 2026. PlexusDx's Trustpilot rating (4.2 stars, 76% five-star, 81% four-star or higher) was captured September 4, 2026.

All 12-month totals and effective monthly averages are our calculations, derived by multiplying the stated monthly rates by the appropriate number of months and dividing totals by 12 where applicable. We assume continuous enrollment with no pauses, dose changes, or plan switches. Real-world costs may vary based on dose escalation timelines, provider visit frequency, and individual treatment duration. Levity's billing cycle is described as approximately four weeks per supply; we model it as monthly for calculation purposes.

This article does not guarantee eligibility, medication availability, dose, or outcomes. Insurance coverage, manufacturer assistance programs, and state-level telehealth or pharmacy regulations may affect net cost and accessibility. Confirm all pricing, coverage, and terms at checkout before committing to any program.

Frequently Asked Questions

Does Levity charge a membership fee on top of the Ozempic cost?

No. Levity's pricing structure, as captured on September 4, 2026, includes a $0 membership fee. The $1,149 first-month charge (with code WELCOME) and $1,199 ongoing monthly charge cover consultation, medication, care access, and shipping with no additional recurring membership or subscription fees beyond the medication cost itself.

Is the $1,149 first-month price available to everyone or only new patients?

The $1,149 first-month Ozempic rate requires the promotional code WELCOME at checkout and represents a $50 discount from the standard $1,199 monthly price. Our research captured this as Levity's standard new-patient promotion on September 4, 2026, but we did not verify eligibility restrictions, expiration dates, or whether returning patients qualify. Confirm at intake whether the discount applies to your enrollment.

What is the actual difference between Levity's branded Ozempic and PlexusDx's compounded semaglutide?

Both contain semaglutide as the active ingredient. Ozempic is an FDA-approved branded medication manufactured by Novo Nordisk under an NDA with Phase III trial data, FDA batch oversight, and post-market surveillance. Compounded semaglutide is prepared by a 503A compounding pharmacy in response to an individual prescription; it is not FDA-approved, and the FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. The price difference—roughly $1,000 per month—reflects the branded pharmaceutical pricing model versus compounding pharmacy cost structure, not a difference in the active ingredient itself.

Can I use insurance or manufacturer coupons to reduce Levity's Ozempic cost?

Our research did not confirm whether Levity accepts insurance billing or Novo Nordisk savings cards (which sometimes reduce out-of-pocket costs for branded Ozempic when prescribed for an FDA-approved indication and filled through certain pharmacies). The $1,149 and $1,199 prices captured appear to be direct-pay cash pricing. Contact Levity directly or check at intake to determine whether your insurance plan or any manufacturer assistance program can be applied to reduce your net cost.

Does the $1,199 per month cover follow-up provider visits or only the medication refill?

Levity's website states that the monthly cost includes "medication, consult, care, and shipping," captured September 4, 2026. The initial consultation is part of the first-month charge; our research did not document whether ongoing months include scheduled follow-up visits or only asynchronous care team access. Clarify with Levity whether dose adjustments, side-effect consultations, or routine check-ins incur separate fees or are bundled into the $1,199 monthly charge.

Sources

• PlexusDx product pricing and service inclusions (captured July 17–23, 2026)
• Levity website, joinlevity.com, pricing and plan details (captured September 4, 2026)
• Levity checkout intake verification session (captured September 4, 2026)
• PlexusDx Trustpilot profile, rating and review distribution (captured September 4, 2026)
• FDA regulatory framework for approved medications and compounded drugs (general reference, no single capture date)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. PlexusDx works with licensed 503A compounding pharmacies. A licensed clinician determines whether a prescription is appropriate for an individual patient.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.